1Chi W, Zhu X, Yang P, et al. Upregulated IL-23 and IL-17 in behcet patients with active uveitis[J]. Invest Ophthalmol Vis Sci, 2008, 49(7): 3058-3064.
2Chi W, Yang P, Li B, et al. IL-23 promotes CD4+ T cells to produce IL-17 in Vogt-Koyanagi-Harada disease[J]. J Allergy Clin Immunol, 2007, 119(5): 1218-1224.
3Wang C, Tian Y, Lei B, et al. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease[J]. Invest Ophthalmol Vis Sci, 2012, 53(8): 4668-4675.
4Zhou Q, Xiao X, Wang C, et al. Decreased microRNA-155 expression in ocular Behcet's disease but not in Vogt-Koyanagi-Harada syndrome[J]. Invest Ophthalmol Vis Sci, 2012, 53(9): 5665-5674.
5Yang Y, Xiao X, Li F, et al. Increased IL-7 expression in Vogt-Koyanagi-Harada disease[J]. Invest Ophthalmol Vis Sci, 2012, 53(2): 1012-1017.
6Liu X, Wang C, Ye Z, et al. Higher expression of Toll-like receptors 2, 3, 4, and 8 in ocular Behcet's disease[J]. Invest Ophthalmol Vis Sci, 2013, 54(9): 6012-6017.
7Qi J, Yang Y, Hou S, et al. Increased notch pathway activation in Behcet's disease[J]. Rheumatology (Oxford), 2014, 53(5): 810-820.
8Wang Q, Qi J, Hu R, et al. Effect of berberine on proinflammatory cytokine production by ARPE-19 cells following stimulation with tumor necrosis factor-α[J]. Invest Ophthalmol Vis Sci, 2012, 53(4): 2395-2402.
9Liu X, Yang P, Wang C, et al. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease[J]. Rheumatology(Oxford),2011,50(2): 293-298.
10Chi W, Yang P, Zhu X, et al. Production of interleukin-17 in Behcet's disease is inhibited by cyclosporin A[J]. Mol Vis, 2010, 16(2010): 880-886.
